Circulation, Vol 82, 2222-2225, Copyright © 1990 by American Heart Association
S Oshima, H Yasue, H Ogawa, K Okumura and K Matsuyama
To examine whether acute myocardial ischemia activates the coagulation
system and platelet activation in the coronary circulation, we measured
plasma levels of fibrinopeptide A and beta-thromboglobulin in the coronary
sinus and the aortic root simultaneously in 15 patients with coronary
spastic angina before and after the left coronary spasm induced by
intracoronary injection of acetylcholine and in 15 patients with stable
exertional angina before and after acute myocardial ischemia induced by
rapid atrial pacing. Fifteen patients with chest pain but normal coronary
arteries and no coronary spasm served as controls. The coronary
sinus-arterial difference of fibrinopeptide A increased markedly (p less
than 0.001) from 0.1 +/- 0.2 to 4.3 +/- 0.7 ng/ml after the anginal attacks
in the coronary spastic angina group. However, fibrinopeptide A levels
remained unchanged after the attacks in the stable exertional angina group
and after intracoronary injection of acetylcholine in the control group.
Plasma beta-thromboglobulin levels remained unchanged after the attacks in
both patient groups and after acetylcholine in the control group. Our data
indicate that coronary spasm induces thrombin generation and may lead to
thrombus formation in the coronary artery involved, but pacing-induced
ischemia does not activate the coagulation system.
ARTICLES
Fibrinopeptide A is released into the coronary circulation after coronary spasm
Division of Cardiology, Kumamoto University Medical School, Japan.
This article has been cited by other articles:
![]() |
R. Jaumdally, C. Varma, R. J. Macfadyen, and G. Y.H. Lip Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment? Eur. Heart J., April 2, 2007; 28(8): 929 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ogawa, H. Soejima, K. Takazoe, S. Miyamoto, I. Kajiwara, H. Shimomura, T. Sakamoto, M. Yoshimura, K. Kugiyama, M. Kimura, et al. Increased Autoantibodies Against Oxidized Low-Density Lipoprotein in Coronary Circulation in Patients with Coronary Spastic Angina Angiology, March 1, 2001; 52(3): 167 - 174. [Abstract] [PDF] |
||||
![]() |
K. Miwa, K. Nakagawa, N. Yoshida, Y. Taguchi, and H. Inoue Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1200 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kaikita, H. Ogawa, H. Yasue, T. Sakamoto, H. Suefuji, H. Sumida, and K. Okumura Soluble P-Selectin Is Released Into the Coronary Circulation After Coronary Spasm Circulation, October 1, 1995; 92(7): 1726 - 1730. [Abstract] [Full Text] |
||||
![]() |
J. Amiral State-of-the-Art Review: Usefulness of Laboratory Techniques for Evaluating Antithrombotic Efficacy of New Therapeutic Strategies Clinical and Applied Thrombosis/Hemostasis, September 1, 1995; 1(4): 243 - 259. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |